Skip to Content

Genenta has been Awarded the First Prize at China-Italy Best Start Up Showcase & Entrepreneurship Competition 2018/2019 (BSSEC). Genenta Presented at the China-Italy Innovation Forum2019 in Beijing (China)

Nov 27, 2019

FOSHAN & BEIJING (China) — Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), announced that they won the first prize at the BSSEC, China-Italy Best Start Up Showcase and Entrepreneurship Competition 2018/2019, on 25th of November in Foshan. The representative of Credit Business of China CICC Wealth Securities, Deepshire Capital, Haozheng Songyue Fund Management Company and the Vice-President of China Association of Inventions were part or the Chinese jury that chose between 12 different start-ups in the six vertical’s project including the life science sector.

Genenta also presented at the China-Italy Innovation Forum in Beijing on 26th of November 2019, at the China National Convention Center. The program included an opening ceremony with the following Government Ministers:

  • Lorenzo Fioramonti, Minister of Education, University and Research, Italian Representative
  • Wang Zhigang, Minister of Science and Technology, Chinese Representative